Figure 2.
CLEAR 1 Study. Proportion of patients achieving a serum UA level of <6.0 mg/dL by month 6 (primary endpoint). Difference between lesinurad 200 mg plus allopurinol group (n=140) versus allopurinol plus placebo group (n=149) was significant (p<0.0001).21
sUA, serum uric acid.